Qisda's Board of Directors Meeting approved
Consolidated financial report of Q4, 2021
Date of events
2022/03/07
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/03/07
2.Date of approval by the audit committee:2022/03/07
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):225,961,031
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):32,556,617
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):7,360,966
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):12,992,346
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):10,482,857
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):8,307,546
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):4.22
11.Total assets end of the period (thousand NTD):187,210,595
12.Total liabilities end of the period
(thousand NTD):121,047,832
13.Equity attributable to owners of parent end of the
period (thousand NTD):41,456,423
14.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
Qisda Corporation published this content on 07 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 March 2022 11:29:02 UTC.
Qisda Corp is a Taiwan-based company principally engaged in the manufacture and sales of liquid crystal displays (LCDs) products. The Company operates through three main segments. The Displays segment is mainly engaged in the manufacture and sales of household and commercial LCD monitors, professional advanced LCD monitors, medical monitors, smart monitors, and public displays. The Projectors segment is primarily involved in the manufacture and sales of commercial, engineering, educational, household and personal mobile projectors. The Medical Services segment is mainly engaged in the provision of general medical diagnosis and treatment services, high-end health examination services, medical cosmetology services and post-natal care services. The Company distributes its products both in domestic markets and to overseas markets.